| Popis: |
Additional file 1: Table S1. The supplementary shows published data for the outcomes for interventions for cerebral malaria. Outcome for intravenous quinine alone was 23% to 26% while combines intravenous quinine and artesunate is 12.5%. Sinclair D, Donegan S, Isba R, Lalloo DG: Artesunate versus quinine for treating severe malaria. The Cochrane Library. 2012, 10.1002/14651858.CD005967.pub4.a Hien TT, Arnold K, Vinh H, et al Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992; 86: 582–83.b Bartoloni A, Tomasoni L, Bartalesi F, Sani S, Zammarchi L, Castelli F, et al. Combined intravenous treatment with artesunate and quinine for severe malaria in Italy. Am J Trop Med Hyg 2010; 83: 274–76.c |
